Home > News > Consortium led by QinetiQ Nanomaterials Ltd wins £2m funding
April 11th, 2006
Consortium led by QinetiQ Nanomaterials Ltd wins £2m funding
Abstract:
A consortium led by QinetiQ Nanomaterials Limited (QNL), a wholly owned QinetiQ subsidiary, is to develop a range of nanomaterials for use in the fight against a broad spectrum of viruses, it was announced today. The two year programme is being funded by the South East England Development Agency (SEEDA) which has allocated £2m to the project, their largest single investment in science and technology to date.
Source:
QinetiQ Nanomaterials
Bookmark:
| Related News Press |
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over 14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||